Azetukalner NDA submitted to FDA for focal seizures

Sponsor

Xenon Pharmaceuticals $XENE

Drug

azetukalner

Indication

Focal seizures

Xenon Pharmaceuticals has filed an NDA with the FDA for azetukalner in focal seizures and updated timelines for its psychiatric development programme.